These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18369326)

  • 1. Cell vehicle targeting strategies.
    Roth JC; Curiel DT; Pereboeva L
    Gene Ther; 2008 May; 15(10):716-29. PubMed ID: 18369326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery.
    Thorne SH; Contag CH
    Gene Ther; 2008 May; 15(10):753-8. PubMed ID: 18356814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taming the Trojan horse: optimizing dynamic carrier cell/oncolytic virus systems for cancer biotherapy.
    Power AT; Bell JC
    Gene Ther; 2008 May; 15(10):772-9. PubMed ID: 18369325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering osteogenesis and chondrogenesis with gene-enhanced therapeutic cells.
    Hao J; Varshney RR; Wang DA
    Curr Opin Mol Ther; 2009 Aug; 11(4):404-10. PubMed ID: 19649985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference as an anticancer therapy: a patent perspective.
    Dykxhoorn DM
    Expert Opin Ther Pat; 2009 Apr; 19(4):475-91. PubMed ID: 19441927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
    Dorer DE; Nettelbeck DM
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy in bladder cancer.
    Bochner BH
    Curr Opin Urol; 2008 Sep; 18(5):519-23. PubMed ID: 18670278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrachromosomal genes: a powerful tool in gene targeting approaches.
    Colosimo A; Guida V; Palka G; Dallapiccola B
    Gene Ther; 2002 Jun; 9(11):679-82. PubMed ID: 12032686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the development of siRNA-based therapeutics for cancer.
    Shen Y
    IDrugs; 2008 Aug; 11(8):572-8. PubMed ID: 18683092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
    Li SD; Huang L
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-chain antibodies: A therapeutic modality for cancer gene therapy (review).
    Leath CA; Douglas JT; Curiel DT; Alvarez RD
    Int J Oncol; 2004 Apr; 24(4):765-71. PubMed ID: 15010813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted gene delivery to the lung.
    Aneja MK; Geiger JP; Himmel A; Rudolph C
    Expert Opin Drug Deliv; 2009 Jun; 6(6):567-83. PubMed ID: 19450167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycol-based vehicles.
    Moore NM; Sheppard CL; Barbour TR; Sakiyama-Elbert SE
    J Gene Med; 2008 Oct; 10(10):1134-49. PubMed ID: 18642401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinspired tissue engineering: the great promise of protein delivery technologies.
    Quaglia F
    Int J Pharm; 2008 Dec; 364(2):281-97. PubMed ID: 18538517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using gene transfer to circumvent off-target effects.
    Miller CP; Blau CA
    Gene Ther; 2008 May; 15(10):759-64. PubMed ID: 18356813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotide delivery: a cellular prospective.
    Liang E; Ajmani PS; Hughes JA
    Pharmazie; 1999 Aug; 54(8):559-66. PubMed ID: 10483609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular gene therapy: a review of nonviral strategies.
    Andrieu-Soler C; Bejjani RA; de Bizemont T; Normand N; BenEzra D; Behar-Cohen F
    Mol Vis; 2006 Oct; 12():1334-47. PubMed ID: 17110916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
    Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
    Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional porous scaffolds at the crossroads of tissue engineering and cell-based gene therapy.
    Coutu DL; Yousefi AM; Galipeau J
    J Cell Biochem; 2009 Oct; 108(3):537-46. PubMed ID: 19681040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.